Pharmacists in Charlton, MA Accepting Medicare

8 Pharmacists found. Showing 1 - 8

Mark Michael Porcaro, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23 Dodge Rd, Charlton, MA 01507 Phone: 617-962-6635

Hannah Whitner, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 142 Worcester Rd, Charlton, MA 01507 Phone: 508-248-5473

James Michael Burke Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 44 Smith Rd, Charlton, MA 01507 Phone: 508-248-7494

Kathryn Ann Eljadidi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 142 Worcester Rd, Charlton, MA 01507 Phone: 508-248-5473

Nancy Colby Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12 A Vinton Rd, Charlton, MA 01507 Phone: 508-248-6982

Christopher Georgiadis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16 Timber Valley Dr, Charlton, MA 01507 Phone: 508-450-6032

Dr. Courtney Thebodo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 142 Worcester Rd, Charlton, MA 01507 Phone: 508-248-5473

Paul Tycz Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7 Mackenzie Dr, Charlton, MA 01507 Phone: 774-258-1529    Fax: 508-248-3868

News Archive

Scientists identify new biomarker linked to non-small cell lung cancer, head and neck cancers

A team led by a scientist from the Florida campus of The Scripps Research Institute has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers.

Study identifies how new ALS gene mutations cause other diseases of the brain, muscle and bone

Researchers supported by The ALS Association have discovered how mutations in new amyotrophic lateral sclerosis (ALS) genes cause not only ALS but also other diseases of the brain, muscle and bone.

Jenex reports closing of modified private-placement equity financing

The Jenex Corporation, a medical device company focused on the development and application of products based on its patented thermal therapy technology, today announced that on December 1, 2009 it closed a brokered private-placement equity financing. The offering is subject to receiving final acceptance from The TSX Venture Exchange.

Living through Hurricane Katrina linked to higher mortality rate among breast cancer patients

Breast cancer patients who endured Hurricane Katrina in 2005 have a 15% higher mortality rate than those patients not exposed to the storm, according to a University of Michigan researcher.

Exercise reverses signs of artery disease in obese children

Healthy but obese adolescents display abnormal responses to tests of blood vessel function, but after a short course of exercise their test results match those of lean youngsters, even though they remain heavy, according to a new study in the May 19, 2004 issue of the Journal of the American College of Cardiology.

Read more Medical News

› Verified 5 days ago